Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human GAPDH ELISA Kit (AC2458)
Cat.#: ASET-1047
Specifications
Description Human GAPDH ELISA Kit allows for the in vitro quantitative determination of human GAPDH concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1489 Human PROX1 ELISA Kit (AC2900) Quantitative inquiry ASET-2078 Rat CDNF ELISA Kit (AC3489) Quantitative inquiry ASET-2215 Human Synaptopodin ELISA Kit (AC3626) Quantitative inquiry ASET-1700 Mouse NG2 ELISA Kit (AC3111) Quantitative inquiry ASET-2030 Human p75 NGF Receptor ELISA Kit (AC3441) Quantitative inquiry ASET-1982 Mouse MRP8 ELISA Kit (AC3393) Quantitative inquiry ASET-2294 Human Hes1 ELISA Kit (AC3705) Quantitative inquiry ASET-1286 Mouse Prion Protein PrP ELISA Kit (AC2697) Quantitative inquiry ASET-1938 Mouse Neurotrophin 3 ELISA Kit (AC3349) Quantitative inquiry ASET-2088 Canine Adenosine A1 Receptor ELISA Kit (AC3499) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket